Código QR

Hepatoprotection by L-Ornithine L-Aspartate in Non-Alcoholic Fatty Liver Disease

Background. Non-alcoholic fatty liver disease (NAFLD) is the leading chronic hepatic condition worldwide and new approaches to management and treatment are limited.Summary. L-ornithine L-aspartate (LOLA) has hepatoprotective properties in patients with fatty liver of diverse etiology and results of...

Descrición completa

Gardado en:
Principais autores: Roger F. Butterworth, Ali Canbay
Formato: Artigo
Idioma:Russo
Publicado: Gastro LLC 2019-03-01
Series:Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Assuntos:
l-ornithine l-aspartate
non-alcoholic fatty liver disease
non-alcoholic steatohepatitis
hepatoprotection
antioxidant
hepatic microcirculation
glutamine
Acceso en liña:https://www.gastro-j.ru/jour/article/view/322
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares